Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

NCT02958865 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

319

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: PF-06651600 or Placebo
DRUG: PF-06700841 or Placebo
DRUG: PF-06700841
DRUG: PF-06651600

Sponsor

Pfizer